AI-Powered Intelligent Infrastructure for Trade Scales Globally as Joint Ventures and Partnerships Accelerate GrowthRevenue Doubled in Second Half 2025 LONDON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- RedClo ...

NextCell Pharma AB ("NextCell" or the "Company") today announces that six-year follow-up data indicate that a single infusion of ProTrans provides a long-lasting and clinically relevant preservation o ...

LinkedIn rewards different signals in 2026. Chris Donnelly brings data-backed insights from analyzing 300,000 posts on what ...

University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...

The first healthy volunteers have been dosed in an early clinical trial testing NRG5051, a disease-modifying therapy for ALS ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

The FDA has granted fast track designation to a vectorized antibody that targets RNA-binding proteins characteristic of ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production ...

Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).

Uysal, B. , Fernandes, M. and Shakhmurzaeva, A. (2026) Sponsorship Disclosure on Instagram: A Systematic Review of Research ...

Rebecca Gayheart may be entitled to a large sum should Eric Dane’s medical condition take a turn for the worse. According to ...

Prefoldin 5 stabilises neuronal microtubules and suppresses Tau-mediated neurotoxicity, offering a potential therapeutic target for tauopathies.